FIL Ltd Has $17.37 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)

FIL Ltd boosted its position in Encompass Health Co. (NYSE:EHC) by 4.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 188,107 shares of the company’s stock after purchasing an additional 8,116 shares during the period. FIL Ltd owned about 0.19% of Encompass Health worth $17,372,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of EHC. MassMutual Private Wealth & Trust FSB lifted its position in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after buying an additional 137 shares during the last quarter. CBIZ Investment Advisory Services LLC raised its stake in Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after acquiring an additional 127 shares during the period. Tompkins Financial Corp acquired a new stake in Encompass Health during the 4th quarter valued at $46,000. V Square Quantitative Management LLC boosted its position in Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after purchasing an additional 177 shares during the period. Finally, Morse Asset Management Inc acquired a new position in shares of Encompass Health in the third quarter valued at $68,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Up 0.1 %

EHC opened at $102.21 on Friday. The stock has a market capitalization of $10.29 billion, a price-to-earnings ratio of 22.92, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a twelve month low of $78.53 and a twelve month high of $104.55. The company has a 50-day simple moving average of $99.56 and a 200 day simple moving average of $98.02.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Insider Buying and Selling

In other news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Barclays upped their target price on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, February 7th. KeyCorp lifted their price target on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Monday, February 10th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. Finally, StockNews.com downgraded Encompass Health from a “buy” rating to a “hold” rating in a report on Thursday, April 3rd. One analyst has rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $107.67.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.